Northern Trust Company of Connecticut’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
$5.14M Buy
+156,589
New +$5.14M 0.03% 679